Atropos Health Secures $30 Million in Funding from McKesson and Merck to Advance Drug Development through Artificial Intelligence

Quick Summary:

Atropos Health raises $30 million in Series B funding to revolutionize healthcare with AI-powered clinical evidence generation, aiming to personalize medical decision-making and accelerate drug development.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Michael Nuñez

Category: StartupsTechnology

Markets: United States

Topics: Category-/Health AI Oncology AI solutions Healthcare AI startups ML and Deep Learning Data Infrastructure Conversational AI Atropos NLP Data Science Business Data Management Series b Automation Series b funding Evidence-based medicine AI Drug development acceleration Personalized medicine Healthcare decision support Atropos Health Value-based care Enterprise Analytics Real-World Evidence AI in healthcare Clinical Evidence Generation

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-05-23 @ 22:08:10 (1 months ago)

News Timezone: GMT -5:00

News Source URL: venturebeat.com

Language: English

Article Length: 26 words

Reading Time: 1 minutes read

Sentences: 28 lines

Sentence Length: 1 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © VentureBeat

News ID: 21069841

View Article Analysis

About VentureBeat

Main Topics: StartupsTechnology

Official Website: venturebeat.com

Update Frequency: 25 posts per day

Year Established: 2005

Headquarters: United States

News Last Updated: 9 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #50

Publisher Details

Frequently Asked Questions